Lazard Asset Management LLC Dexcom Inc Transaction History

Lazard Asset Management LLC

$82.4 Billion
Q1 2024

A detailed history of Lazard Asset Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 32,423 shares of DXCM stock, worth $3.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

32,423

Previous 47,005 31.02%

Holding current value

$3.65 Million

Previous $5.83 Million 22.89%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $1.67 Million - $2.04 Million	-14,582 Reduced 31.02%	32,423 $4.5 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $48,313 - $79,462	640 Added 1.38%	47,005 $5.83 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $71,257 - $114,206	-828 Reduced 1.75%	46,365 $4.33 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $84,015 - $97,842	747 Added 1.61%	47,193 $6.06 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $3.26 Million - $3.85 Million	-31,357 Reduced 40.3%	46,446 $5.4 Million

Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $4.98 Million - $7.19 Million	-58,635 Reduced 42.98%	77,803 $8.81 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $24,966 - $30,796	327 Added 0.24%	136,438 $11 Million
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $7.74 Million - $15.1 Million	113,769 Added 509.22%	136,111 $10.1 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $367,570 - $508,691	3,907 Added 21.19%	22,342 $11.4 Million
Q4 2021 Feb 09, 2022	BUY	$129.87 - $162.82 $752,986 - $944,030	5,798 Added 45.88%	18,435 $9.9 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $172,123 - $230,949	-1,613 Reduced 11.32%	12,637 $6.91 Million
Q2 2021 Aug 12, 2021	BUY	$80.99 - $107.93 $1.02 Million - $1.36 Million	12,647 Added 788.96%	14,250 $6.08 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $37,222 - $45,980	439 Added 37.71%	1,603 $575,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $8,736 - $11,704	112 Added 10.65%	1,164 $429,000
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $61,050 - $102,601	974 Added 1248.72%	1,052 $426,000
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $3,727 - $5,899	78 New	78 $21,000
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $128,609 - $201,202	-3,512 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $72,587 - $89,483	-2,043 Reduced 36.78%	3,512 $524,000
Q1 2019 May 13, 2019	BUY	$28.07 - $38.18 $155,928 - $212,089	5,555 New	5,555 $661,000
Q2 2018 Aug 13, 2018	SELL	$17.54 - $25.22 $249,085 - $358,149	-14,201 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$13.06 - $18.54 $173,711 - $246,600	13,301 Added 1477.89%	14,201 $1.05 Million
Q2 2015 Jul 08, 2019	BUY	N/A	810 Added 900.0%	900 $71,000
Q4 2014 Aug 29, 2019	BUY	N/A	90	90 $4,000

Others Institutions Holding DXCM

# of Institutions

1,123

Shares Held

353M

Call Options Held

4.19M

Put Options Held

4.54M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Dexcom Inc Transaction History